In SLE study, we observed the significant increase of natural killer (NK) cells in response to Ld-IL2 treatment, which implicated potential augmentation of anti-infection cellular immunity.22 We also found that CD56bri NK cells were increased in association with Ld-IL2 administration (Supplementary Fig. 2). This evidence concerns the gene IL2 and systemic lupus erythematosus.